Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$25.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 26 most recent Form 4 transactions.
| Aug 12 | MRK | Merck & Co., Inc. | SSELL | 80,315 | $133.46 | $10.7M | -63.8% | Open the original filing on SEC.gov |
| Aug 12 | MRK | Merck & Co., Inc. | MEXER | 13,433 | $84.71 | $1.1M | +11.9% | Open the original filing on SEC.gov |
| Aug 12 | MRK | Merck & Co., Inc. | MEXER | 41,494 | $117.89 | $4.9M | +58.5% | Open the original filing on SEC.gov |
| May 29 | RGNX | REGENXBIO Inc. | AGRANT◆ | 46,600 | — | — | — | Open the original filing on SEC.gov |
| May 29 | RGNX | REGENXBIO Inc. | AGRANT | 9,807 | — | — | +44.5% | Open the original filing on SEC.gov |
| May 5 | MRK | Merck & Co., Inc. | AGRANT◆ | 35,312 | — | — | — | Open the original filing on SEC.gov |
| May 5 | MRK | Merck & Co., Inc. | AGRANT◆ | 12,064 | — | — | — | Open the original filing on SEC.gov |
| Apr 29 | MRK | Merck & Co., Inc. | MEXER◆ | 2,951 | — | — | — | Open the original filing on SEC.gov |
| Apr 29 | MRK | Merck & Co., Inc. | FTAX | 1,454 | $110.03 | $160K | -2.0% | Open the original filing on SEC.gov |
| Apr 29 | MRK | Merck & Co., Inc. | MEXER | 2,951 | $110.03 | $324.7K | +4.3% | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | MEXER◆ | 38,835 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | MEXER◆ | 56,792 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | MEXER◆ | 25,946 | — | — | — | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | SSELL | 38,835 | $119.15 | $4.6M | -36.0% | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | MEXER | 38,835 | $119.15 | $4.6M | +56.4% | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | SSELL | 56,792 | $119.15 | $6.8M | -45.2% | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | MEXER | 56,792 | $119.15 | $6.8M | +82.4% | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | SSELL | 25,946 | $119.15 | $3.1M | -27.4% | Open the original filing on SEC.gov |
| Feb 9 | MRK | Merck & Co., Inc. | MEXER | 25,946 | $119.15 | $3.1M | +37.6% | Open the original filing on SEC.gov |
| Jan 26 | MRK | Merck & Co., Inc. | AGRANT | 11,583 | $107.40 | $1.2M | +20.2% | Open the original filing on SEC.gov |
| May 30, 2025 | RGNX | REGENXBIO Inc. | AGRANT◆ | 39,815 | — | — | — | Open the original filing on SEC.gov |
| May 30, 2025 | RGNX | REGENXBIO Inc. | AGRANT | 7,768 | — | — | +54.3% | Open the original filing on SEC.gov |
| Apr 29, 2025 | MRK | Merck & Co., Inc. | AGRANT◆ | 40,301 | — | — | — | Open the original filing on SEC.gov |
| Apr 29, 2025 | MRK | Merck & Co., Inc. | AGRANT◆ | 8,854 | — | — | — | Open the original filing on SEC.gov |